Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives. [Review]
- 2014
Available in print through MWHC library: 2002 - present
Over the last decade, the introduction of drug-eluting stents has dramatically reduced restenosis and the need for repeat revascularization after implantation of metallic stents. Numerous concerns still remain, however, because of their permanent nature. Thus, the concept of bioresorbable temporary scaffolds composed of biocompatible materials has emerged as a potential alternative to permanent metal stents. Here we focus on metal alloys & discuss preclinical and clinical experiences with bioresorbable metal scaffolds. Copyright © 2014. Published by Elsevier Inc.
English
1878-0938
*Absorbable Implants
*Coronary Artery Disease/th [Therapy]
*Endovascular Procedures/is [Instrumentation]
*Percutaneous Coronary Intervention/is [Instrumentation]
*Peripheral Arterial Disease/th [Therapy]
*Stents
*Tissue Scaffolds
Animals
Coronary Artery Disease/di [Diagnosis]
Drug-Eluting Stents
Endovascular Procedures/ae [Adverse Effects]
Humans
Metals
Percutaneous Coronary Intervention/ae [Adverse Effects]
Peripheral Arterial Disease/di [Diagnosis]
Prosthesis Design
Treatment Outcome
MedStar Heart & Vascular Institute
Journal Article
Review